The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Canon Medical Systems USA for use of its artificial intelligence-based Advanced Intelligent Clear-IQ Engine (AiCE) image reconstruction technology with its Aquilion Precision ultrahigh-resolution CT scanner.
Following previous FDA clearance for AiCE CT reconstruction software, the technology now has regulatory clearance for application to ultrahigh-resolution CT scans. Clinicians can thus use the deep convolutional neural network image reconstruction technology of AiCE to roughly double the spatial resolution of conventional CT scans at equivalent radiation doses, according to the company.
AiCE is capable of suppressing image noise while enhancing signal three to five times more quickly than traditional model-based iterative reconstruction (MBIR) methods, Canon said.
